The local option is 'recombinant' or 'downstream' production

Confirmation there is no prospect Australia can manufacture from scratch and under license one of the mRNA or adenovirus viral vector COVID-19 vaccines currently in development as South Korea becomes the latest country to secure supply of one of the leading candidates. …